DE60114448D1 - Imidazolonderivate zur behandlung viraler krankheiten - Google Patents
Imidazolonderivate zur behandlung viraler krankheitenInfo
- Publication number
- DE60114448D1 DE60114448D1 DE60114448T DE60114448T DE60114448D1 DE 60114448 D1 DE60114448 D1 DE 60114448D1 DE 60114448 T DE60114448 T DE 60114448T DE 60114448 T DE60114448 T DE 60114448T DE 60114448 D1 DE60114448 D1 DE 60114448D1
- Authority
- DE
- Germany
- Prior art keywords
- imidazolon
- derivatives
- treatment
- viral diseases
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0028484.4A GB0028484D0 (en) | 2000-11-22 | 2000-11-22 | Imidazolone derivatives for the treatment of viral diseases |
GB0028484 | 2000-11-22 | ||
PCT/EP2001/013069 WO2002042279A1 (en) | 2000-11-22 | 2001-11-12 | Imidazolone derivatives for the treatment of viral diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60114448D1 true DE60114448D1 (de) | 2005-12-01 |
DE60114448T2 DE60114448T2 (de) | 2006-07-06 |
Family
ID=9903671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60114448T Expired - Fee Related DE60114448T2 (de) | 2000-11-22 | 2001-11-12 | Imidazolonderivate zur behandlung viraler krankheiten |
Country Status (20)
Country | Link |
---|---|
US (1) | US6518293B2 (de) |
EP (1) | EP1341766B1 (de) |
JP (1) | JP2004514672A (de) |
KR (1) | KR100528760B1 (de) |
CN (1) | CN1633417A (de) |
AR (1) | AR035372A1 (de) |
AT (1) | ATE307805T1 (de) |
AU (2) | AU2002221842B2 (de) |
BR (1) | BR0115476A (de) |
CA (1) | CA2428461A1 (de) |
DE (1) | DE60114448T2 (de) |
DK (1) | DK1341766T3 (de) |
ES (1) | ES2251529T3 (de) |
GB (1) | GB0028484D0 (de) |
MX (1) | MXPA03004454A (de) |
PA (1) | PA8533301A1 (de) |
PE (1) | PE20020636A1 (de) |
UY (1) | UY27035A1 (de) |
WO (1) | WO2002042279A1 (de) |
ZA (1) | ZA200303690B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200423930A (en) * | 2003-02-18 | 2004-11-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitors |
JP2007532626A (ja) * | 2004-04-14 | 2007-11-15 | ファイザー・インク | Hiv治療用硫黄連結イミダゾール化合物 |
US20080176919A1 (en) * | 2005-01-06 | 2008-07-24 | Pfizer Inc | Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators |
WO2008085008A1 (en) * | 2007-01-11 | 2008-07-17 | Mogam Biotechnology Research Institute | T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
KR101110120B1 (ko) * | 2009-10-28 | 2012-01-31 | 주식회사 케이아이테크놀로지 | 표지판 완충장치 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4345936A (en) * | 1981-10-05 | 1982-08-24 | Eli Lilly And Company | Imidazoles, compositions and herbicidal method |
TW235963B (de) | 1992-01-16 | 1994-12-11 | Shionogi & Co | |
WO1993015060A1 (en) | 1992-01-22 | 1993-08-05 | Nissan Chemical Industries, Ltd. | Substituted pyrazole derivative and agrohorticultural bactericide |
GB9222262D0 (en) | 1992-10-23 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
US5612636A (en) * | 1995-01-19 | 1997-03-18 | Texas Instruments Incorporated | Short circuit power optimization for CMOS circuits |
US5612363A (en) | 1995-06-02 | 1997-03-18 | Berlex Laboratories, Inc. | N,N-di(aryl) cyclic urea derivatives as anti-coagulants |
US6046331A (en) * | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
-
2000
- 2000-11-22 GB GBGB0028484.4A patent/GB0028484D0/en not_active Ceased
-
2001
- 2001-11-06 US US09/993,848 patent/US6518293B2/en not_active Expired - Fee Related
- 2001-11-12 MX MXPA03004454A patent/MXPA03004454A/es active IP Right Grant
- 2001-11-12 AU AU2002221842A patent/AU2002221842B2/en not_active Ceased
- 2001-11-12 CA CA002428461A patent/CA2428461A1/en not_active Abandoned
- 2001-11-12 AU AU2184202A patent/AU2184202A/xx active Pending
- 2001-11-12 WO PCT/EP2001/013069 patent/WO2002042279A1/en active IP Right Grant
- 2001-11-12 AT AT01997479T patent/ATE307805T1/de not_active IP Right Cessation
- 2001-11-12 DE DE60114448T patent/DE60114448T2/de not_active Expired - Fee Related
- 2001-11-12 DK DK01997479T patent/DK1341766T3/da active
- 2001-11-12 EP EP01997479A patent/EP1341766B1/de not_active Expired - Lifetime
- 2001-11-12 KR KR10-2003-7006881A patent/KR100528760B1/ko not_active IP Right Cessation
- 2001-11-12 JP JP2002544414A patent/JP2004514672A/ja active Pending
- 2001-11-12 ES ES01997479T patent/ES2251529T3/es not_active Expired - Lifetime
- 2001-11-12 CN CNA018193528A patent/CN1633417A/zh active Pending
- 2001-11-12 BR BR0115476-1A patent/BR0115476A/pt not_active IP Right Cessation
- 2001-11-20 PE PE2001001158A patent/PE20020636A1/es not_active Application Discontinuation
- 2001-11-21 UY UY27035A patent/UY27035A1/es not_active Application Discontinuation
- 2001-11-21 AR ARP010105422A patent/AR035372A1/es not_active Application Discontinuation
- 2001-11-21 PA PA20018533301A patent/PA8533301A1/es unknown
-
2003
- 2003-05-13 ZA ZA200303690A patent/ZA200303690B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1341766B1 (de) | 2005-10-26 |
AU2002221842B2 (en) | 2007-08-23 |
CN1633417A (zh) | 2005-06-29 |
US6518293B2 (en) | 2003-02-11 |
DK1341766T3 (da) | 2006-02-20 |
JP2004514672A (ja) | 2004-05-20 |
GB0028484D0 (en) | 2001-01-10 |
US20020107272A1 (en) | 2002-08-08 |
ES2251529T3 (es) | 2006-05-01 |
PA8533301A1 (es) | 2002-08-26 |
EP1341766A1 (de) | 2003-09-10 |
MXPA03004454A (es) | 2003-08-19 |
DE60114448T2 (de) | 2006-07-06 |
PE20020636A1 (es) | 2002-07-18 |
BR0115476A (pt) | 2003-08-19 |
CA2428461A1 (en) | 2002-05-30 |
AR035372A1 (es) | 2004-05-12 |
ZA200303690B (en) | 2004-08-13 |
KR100528760B1 (ko) | 2005-11-15 |
UY27035A1 (es) | 2002-06-20 |
WO2002042279A1 (en) | 2002-05-30 |
ATE307805T1 (de) | 2005-11-15 |
KR20030060951A (ko) | 2003-07-16 |
AU2184202A (en) | 2002-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
FIU20060389U0 (fi) | Luusairauksien hoito | |
DE60219292D1 (de) | Pyrazolderivate zur behandlung von hiv | |
DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
NO20031615D0 (no) | Pyrazol-derivater for behandling av virus-sykdommer | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
DE60236743D1 (de) | Zur behandlung androgenabhängiger krankheiten | |
DE60218375D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
DE60006412D1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
DE60130691D1 (de) | Indolderivate zur Behandlung von Erkrankungen des Zentralnervensystems | |
DE60114448D1 (de) | Imidazolonderivate zur behandlung viraler krankheiten | |
DE60120961D1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen | |
ATE251167T1 (de) | Oxazinocarbazole zur behandlung von cns- erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |